The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...
More than three years after approving two biosimilars referencing Sanofi’s long-acting insulin Lantus, the FDA has ... dose or in a multiple-dose 10 mL vial. It is for adults and pediatric ...
Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting ... to lower the price of its best-selling insulin product, Lantus (insulin glargine), by 78%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback